| Literature DB >> 23935106 |
Amanda Petrina Scotá Ferreira1, Alexandre Cassago, Kaliandra de Almeida Gonçalves, Marília Meira Dias, Douglas Adamoski, Carolline Fernanda Rodrigues Ascenção, Rodrigo Vargas Honorato, Juliana Ferreira de Oliveira, Igor Monteze Ferreira, Camila Fornezari, Jefferson Bettini, Paulo Sérgio Lopes Oliveira, Adriana Franco Paes Leme, Rodrigo Villares Portugal, Andre Luis Berteli Ambrosio, Sandra Martha Gomes Dias.
Abstract
The phosphate-dependent transition between enzymatically inert dimers into catalytically capable tetramers has long been the accepted mechanism for the glutaminase activation. Here, we demonstrate that activated glutaminase C (GAC) self-assembles into a helical, fiber-like double-stranded oligomer and propose a molecular model consisting of seven tetramer copies per turn per strand interacting via the N-terminal domains. The loop (321)LRFNKL(326) is projected as the major regulating element for self-assembly and enzyme activation. Furthermore, the previously identified in vivo lysine acetylation (Lys(311) in humans, Lys(316) in mouse) is here proposed as an important down-regulator of superoligomer assembly and protein activation. Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide, a known glutaminase inhibitor, completely disrupted the higher order oligomer, explaining its allosteric mechanism of inhibition via tetramer stabilization. A direct correlation between the tendency to self-assemble and the activity levels of the three mammalian glutaminase isozymes was established, with GAC being the most active enzyme while forming the longest structures. Lastly, the ectopic expression of a fiber-prone superactive GAC mutant in MDA-MB 231 cancer cells provided considerable proliferative advantages to transformed cells. These findings yield unique implications for the development of GAC-oriented therapeutics targeting tumor metabolism.Entities:
Keywords: Cancer; Enzyme Inhibitors; Enzyme Mechanisms; Glutaminase; Metabolism; Warburg Effect
Mesh:
Substances:
Year: 2013 PMID: 23935106 PMCID: PMC3784714 DOI: 10.1074/jbc.M113.501346
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157